Effects of trauma quality improvement program implementation on mortality: A nonrandomized controlled trial

Johanna Berg,Siddarth David,Girish Bakhshi,Debojit Basak,Shamita Chatterjee,Kapil Dev Soni,Ulf Ekelund,Li Felländer-Tsai,Manjul Joshipura,Tamal Khan,Monty Khajanchi,Mohan L N,Anurag Mishra,Max Petzold,Sendhil Rajan,Nobhojit Roy,Rajdeep Singh,Martin Gerdin Wärnberg

DOI: https://doi.org/10.1101/2024.05.27.24307748

2024-09-25

Abstract:Importance: Trauma causes over four million deaths annually, predominantly in low− and middle−income countries. Implementing trauma quality improvement programs may improve outcomes, and though extensively used, high−quality evidence of their effectiveness is scarce. Objective: To assess if implementing a trauma quality improvement program using on audit filters improves trauma patients' outcomes. Design: A controlled interrupted time−series study. Setting: Prospective, multicenter study across four tertiary care hospitals in urban India between 2017−2022. Participants: Adult patients admitted to participating hospitals with history a of trauma, defined as having any of the external causes listed in block V01−Y36, chapter XX of the ICD−10 as reason for admission. Intervention: In the intervention arm (two hospitals), a trauma quality improvement program using audit filters was implemented after a one−year observation period. The control arm (two hospitals) continued baseline data collection without intervention throughout the study period. Main Outcomes: All−cause mortality (in−hospital and at 30 days). For time series analysis, segmented regression with a generalized additive model (GAM) assessed the effect on in−hospital mortality. Secondary analysis using difference−in−differences and linear regression assessed in−hospital and 30−day mortality. The study was not powered for time series analysis on 30−day mortality. Results: We included 10143 patients, median age 35 (IQR 26 − 50), 83% men and found a crude 8% reduction (95% CI −11% to −5.3%, p\<0.001)* in in-hospital mortality and 14% reduction *(95% CI −18% to −9.6%, p\<0.001)* in 30-day mortality in the intervention arm. Using time series analysis, we observed a significant reduction in in−hospital mortality (32% vs 24%; OR 0.56, 95% CI 0.4−0.77, p<0.001) in the intervention arm, with no significant change in the control arm. Difference−in−differences analysis found a significant reduction in 30−day mortality (39% vs 26%; DiD estimate −0.15 95% CI −0.19 to −0.11, p<0.001) and in−hospital mortality (32% vs 24%; DiD estimate −0.12 95% CI −0.16 to −0.09, p<0.001). However, external factors such as the opening of a dedicated trauma center at one intervention hospital and the COVID−19 pandemic may have influenced these results. Conclusion: Implementing a trauma quality improvement program using audit filters may reduce mortality. More research is needed to confirm these findings across different settings and to understand by which mechanisms these programs mediate the effect and ensure sustainability in terms of improving outcomes. Trial registration: Trauma Audit Filter Trial, ClinicalTrials.gov ID , https://clinicaltrials.gov/study/